NL-OMON46880
Completed
Not Applicable
The MILESTONE study: Improving Transition from Child to Adult Mental Health Care - MILESTONE: Improving transition from CAMHS to AMHS
The University of Warwick - Warwick Medical School0 sites428 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Psychiatric disorders
- Sponsor
- The University of Warwick - Warwick Medical School
- Enrollment
- 428
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria of young people attending CAMHS (2\.5\.3\. in protocol):
- •1\. Provides valid written informed consent, or assent, if below the legal age of consent.
- •2\. If age is within one year of reaching the transition boundary of their CAMHS during the trial recruitment period and, in exceptional cases, not more than 3 months older than the transition boundary.
- •3\. Has a mental disorder defined by DSM\-IV\-TR, DSM\-5 or ICD 10/11, or is under the regular care of CAMHS (if not yet diagnosed).
- •4\. Has an IQ \* 70 as ascertained by previous standardized assessment or diagnosed by clinician, or no indication of intellectual impairment.;Inclusion criteria of parents/carers (2\.5\.5\. in protocol)
- •1\. Only one parent/carer per young person can be recruited into the study, the aim being to engage the same individual throughout the study. If the latter is not possible, then the aim is to involve another parent/carer.
- •2\. If the young person doesn\*t live with his/her biological parent/s, then his/her carer will be involved. A carer may be the legal guardian or a partner or an older adult sibling, or another individual living with and/or providing regular support to the young person.
- •3\. For young people under the legal age of consent, the parent/carer has to be the legal guardian of the young person.
- •4\. Young person consents to parent/carer participation.
- •5\. Parent/carer provides a valid written informed consent.;Inclusion criteria of clinicians/care providers (2\.5\.7 in protocol)
Exclusion Criteria
- •Exclusion criteria of young people attending CAMHS (2\.5\.4\. in protocol):
- •1\. Does not provide valid written informed consent, or assent, if below the legal age of consent.
- •2\. Is younger than a year before the transition boundary of their CAMHS.
- •3\. Has intellectual impairment (IQ \< 70\) as ascertained by previous standardized assessment or diagnosed by clinician.
- •If no data on intellectual functioning are available (because it has never been assessed) then care coordinators will be asked to make a clinical judgement on intellectual impairment before baseline assessment takes place.
- •4\. If not able to (or expected not to be able to) complete the questionnaires due to severe physical disabilities or language problems, even with assistance from family members or research assistant.
- •5\. Service user in a secure forensic institution;Exclusion criteria of parents/carers (2\.5\.6\. in protocol)
- •1\. A parent/carer who does not live with and/or provide regular support to young person.
- •2\. Young person does not provide consent for parent/carer participation.
- •3\. Parent/carer does not provide a valid written consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A prospective, multi-centre study investigating the incidence and prognosis of relapses, pseudo-relapses and other causes of (sub)acute neurological symptoms in patients with relapsing-remitting multiple sclerosis.NL-OMON55562Sint Elisabeth Ziekenhuis125
Completed
Not Applicable
A prospective cohort study to improve the AccUracy of Referrals to the emerGency departmEnt of patieNts with chesT pain: to decrease the delay in acute coronary syndrome patients and rule out non-cardiac chest pain patients (URGENT)acute coronary syndromehartattack10082206NL-OMON45470Viecuri Medisch Centrum voor Noord-Limburg40
Completed
Phase 3
A Multicenter Randomized Controlled Trial to Compare the Efficacy of End-ischemic Dual Hypothermic Oxygenated Perfusion with Standard Static Cold Storage of Liver Grafts Donated after Circulatory Death in Preventing Non-anastomotic Biliary Strictures after TransplantatioEnd-stage liver disease100179431001965410019818NL-OMON47263niversitair Medisch Centrum Groningen120
Completed
Not Applicable
Beat-It: A pilot study on the practicality and effectiveness of a m-health application in improving emotion regulation in adolescents with externalizing disorder.ADHDConduct Disorder10021563NL-OMON40187Yulius26
Completed
Phase 2
An uncontrolled, pilot-study assessing the efficacy of octreotide LAR to decrease transfusion requirements and endoscopy frequency in patients with Rendu-Osler-Weber and gastrointestinal bleedingRendu-Osler-Weber and Hereditary hemorrhagic telangiectasia10017959NL-OMON43279Maag-, darm- en leverziekten11